This Article Full Text Full Text (PDF) Other Versions of this Article: JVI.02445-06v1 81/7/3303    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by El-Guindy, A. Articles by Miller, G. Search for Related Content PubMed PubMed Citation Articles by El-Guindy, A. Articles by Miller, G.

Phosphoacceptor Site S173 in the Regulatory Domain of Epstein-Barr Virus ZEBRA Protein Is Required for Lytic DNA Replication but Not for Activation of Viral Early Genes

Departments of Molecular Biophysics and Biochemistry,¹ Pediatrics,³ Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06520,⁵ Department of Molecular Biology, National Research Center, Cairo, Egypt,² Department of Tumor Virology, German Cancer Research Center, Im Neuenheimer Feld 242, Heidelberg, Germany⁴

Received 6 November 2006/ Accepted 28 December 2006

The Epstein-Barr virus ZEBRA protein controls the viral lytic cycle. ZEBRA activates the transcription of viral genes required for replication. ZEBRA also binds to oriLyt and interacts with components of the viral replication machinery. The mechanism that differentiates the roles of ZEBRA in regulation of transcription and initiation of lytic replication is unknown. Here we show that S173, a residue in the regulatory domain, is obligatory for ZEBRA to function as an origin binding protein but is dispensable for its role as a transcriptional activator of early genes. Serine-to-alanine substitution of this residue, which prevents phosphorylation of S173, resulted in a threefold reduction in the DNA binding affinity of ZEBRA for oriLyt, as assessed by chromatin immunoprecipitation. An independent assay based on ZEBRA solubility demonstrated a marked defect in DNA binding by the Z(S173A) mutant. The phenotype of a phosphomimetic mutant, the Z(S173D) mutant, was similar to that of wild-type ZEBRA. Our findings suggest that phosphorylation of S173 promotes viral replication by enhancing ZEBRA's affinity for DNA. The results imply that stronger DNA binding is required for ZEBRA to activate replication than that required to activate transcription.

Published ahead of print on 10 January 2007.